NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
25/06/2024
Voltar para busca
Dado oficial do USPTO
PATIENTS CAN'T WAIT. NEITHER CAN WE.
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
PATIENTS CAN'T WAIT. NEITHER CAN WE.
ST13
US500000090066400Classe
42, 44
Pedido
90066400
Registro
7429611
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
43
Atualização mais recente
25/06/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42, 44
Data de depósito
22/07/2020
Data de registro
25/06/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
25/06/2024
Última transação
25/06/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
2023-09-00
Primeiro uso no comércio
2023-09-00
Código do desenho
4
Tipo de titular
03
Localização do titular
PRINCETON, NJ
Examinador
SCHLEGELMILCH, JONATHON
Unidade examinadora
L80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
LABCORP DRUG DEVELOPMENT INC.
Covance, Inc.
Representantes
William M. Bryner KILPATRICK TOWNSEND & STOCKTON LLP
Classificação técnica
Classes Nice
Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Scientific research and development; pharmaceutical drug development and testing services; research and development of pharmaceuticalsmedical devicesbiotechnologybiochemicals; medical and scientific researchdesigningorganizingconductingmonitoringmanaging clinical and non-clinical trials and studies on pharmaceuticals and medical devices for others; scientific consulting services for others in the field of clinical and non-clinical trials and studies on pharmaceuticals and medical devices; collectioncalibrationanalysis and reporting of medical and scientific research data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; scientific laboratory services; scientific laboratory servicesformulating and bioprocessing pharmaceuticals; operating and maintaining a biorepository for medical and scientific research purposes; scientific research and analysis in the fields of bioinformaticsbiomarkersgenomicsproteomicsgenotypinggenetic profiling; custom design and development of chemical reagents and biochemical assays; medical laboratory services in the field of pathology; computer hardware and software design; design and development of software for use in conducting biological research in non-clinical pharmaceutical and medical device and development studies; providing online computer databases in the fields of research and development of pharmaceuticalsmedical devicesbiotechnologybiochemicals; data mining; providing a website featuring technology enabling users to remotely trackmonitoranalyzegenerate reports with information and statistics from clinical and non-clinical trials and studies on pharmaceuticals and medical devices; scientific research and analysis in the field of pharmacology; advisory services in the field of pharmaceutical drug developmentselecting biological research models for use in testing drugs; advisory services in the field of pharmaceutical drug developmentselecting biomarkers for use in testing drugs; lead candidate drug optimization servicesscientific research in the field of identifying compounds for drug development; providing medical and scientific information in the fields of biochemistrypharmaceuticals and clinical trials; acting as an application service provider featuring software for use in database and record management in the fields of medical testingtesting for forensic purposestesting for quality control purposesgenetic testingclinical and analytical testingdiseasemedical carehealthcarepharmaceuticalsmedical devicesbiochemicalsbiotechnology; providing non-downloadable software through a web-based portal to collectorganizereport medical informationmedical recordsdiagnostic testing records; providing a web-based portal in the fields of medical testing for scientific research purposestesting for forensic research purposestesting for quality control purposesgenetic testing for scientific research purposesmedical and scientific research in the field ofdiseasemedical carehealthcarepharmaceuticalsmedical devicesbiochemicalsbiotechnology; providing temporary use of online non-downloadable software for storingretrievingaccessingdisplayingmanaginganalyzingreviewing information and data in the fields of medical testingtesting for forensic purposestesting for quality control purposesgenetic testingclinical and analytical testingdiseasemedical carehealthcarepharmaceuticalsmedical devicesbiochemicalsbiotechnology; electronic storage of data; consulting services in the fields of testing for drugalcohol and DNA screening for forensic research purposes and testing for quality control purposes; providing an online computer database in the fields of testing for drugalcohol and DNA screening for forensic research purposes and testing for quality control purposes; providing a website featuring information in the fields of testing for drugalcohol and DNA screening for forensic research purposes and testing for quality control purposes; medical testing for quality control purposes
Classe 44
Medical services in the fields of pathologypharmacologyimmunology; medical and psychological counseling; medical testing for diagnostictreatmentscreening purposes; medical testing for forensic purposes; genetic testing for medical purposes; medical testing for diagnostic and treatment purposes; consulting services in the fields of medical testingtesting for medical forensic purposesgenetic testing for medical purposes and relating to diagnosticprophylactic and therapeutic information in the fields of diseasemedical care and healthcare; medical consulting in the field of patient management and outcomes; providing an online computer database in the fields of medical testingtesting for medical forensic purposesgenetic testing for medical purposes and relating to diagnosticprophylactic and therapeutic information in the fields of diseasemedical carehealthcare; providing an online computer database featuring medical information in the field of patient management and outcomes; providing a website featuring information in the fields of medical testingtesting for medical forensic purposesgenetic testing for medical purposes and relating to diagnosticprophylactic and therapeutic information in the fields of diseasemedical carehealthcare; providing a website featuring medical information in the field of patient management and outcomes
Publicações
Histórico de despachos e eventos da marca no USPTO.
43 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
25/06/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
23/05/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
23/05/2024
DOCK
ASSIGNED TO EXAMINER
16/05/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
22/02/2024
IUAF
USE AMENDMENT FILED
15/02/2024
EISU
TEAS STATEMENT OF USE RECEIVED
15/02/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
25/08/2023
EX5G
SOU EXTENSION 5 GRANTED
24/08/2023
EXT5
SOU EXTENSION 5 FILED
15/08/2023
EEXT
SOU TEAS EXTENSION RECEIVED
15/08/2023
NOAC
CORRECTED NOA E-MAILED
24/06/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
31/05/2023
EX4G
SOU EXTENSION 4 GRANTED
30/05/2023
DPCC
DIVISIONAL PROCESSING COMPLETE
30/05/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
25/04/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
13/03/2023
EXT4
SOU EXTENSION 4 FILED
16/02/2023
DRRR
DIVISIONAL REQUEST RECEIVED
16/02/2023
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
16/02/2023
EEXT
SOU TEAS EXTENSION RECEIVED
16/02/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/09/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
17/08/2022
EX3G
SOU EXTENSION 3 GRANTED
15/08/2022
EXT3
SOU EXTENSION 3 FILED
15/08/2022
EEXT
SOU TEAS EXTENSION RECEIVED
15/08/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
18/02/2022
EX2G
SOU EXTENSION 2 GRANTED
16/02/2022
EXT2
SOU EXTENSION 2 FILED
16/02/2022
EEXT
SOU TEAS EXTENSION RECEIVED
16/02/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
18/08/2021
EX1G
SOU EXTENSION 1 GRANTED
16/08/2021
EXT1
SOU EXTENSION 1 FILED
16/08/2021
EEXT
SOU TEAS EXTENSION RECEIVED
16/08/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
16/02/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/12/2020
PUBO
PUBLISHED FOR OPPOSITION
22/12/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/12/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/11/2020
DOCK
ASSIGNED TO EXAMINER
06/11/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/08/2020
NWAP
NEW APPLICATION ENTERED
25/07/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PATIENTS CAN'T WAIT. NEITHER CAN WE. ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.